Oxford Biomedica plc
OXB.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | £54 | £61 | £81 | £104 |
| Short-Term Investments | £0 | £0 | £0 | £0 |
| Receivables | £57 | £42 | £26 | £13 |
| Inventory | £16 | £14 | £17 | £13 |
| Other Curr. Assets | £5 | £17 | £15 | £11 |
| Total Curr. Assets | £132 | £133 | £139 | £141 |
| Property Plant & Equip (Net) | £55 | £64 | £72 | £76 |
| Goodwill | £0 | £0 | £0 | £0 |
| Intangibles | £24 | £29 | £30 | £31 |
| Long-Term Investments | £5 | £5 | £5 | £4 |
| Tax Assets | £0 | £0 | £0 | -£4 |
| Other NC Assets | £0 | £0 | £0 | £4 |
| Total NC Assets | £85 | £98 | £106 | £111 |
| Other Assets | £0 | £0 | £0 | £0 |
| Total Assets | £216 | £232 | £245 | £252 |
| Liabilities | – | – | – | – |
| Payables | £10 | £10 | £13 | £6 |
| Short-Term Debt | £5 | £4 | £5 | £7 |
| Tax Payable | £0 | £0 | £0 | £1 |
| Deferred Revenue | £42 | £0 | £0 | £22 |
| Other Curr. Liab. | £13 | £44 | £41 | £7 |
| Total Curr. Liab. | £70 | £58 | £59 | £44 |
| LT Debt | £101 | £104 | £105 | £108 |
| Deferred Rev, NC | £6 | £1 | £1 | £5 |
| Deferred Tax Liab, NC | £0 | £0 | £0 | £0 |
| Other NC Liab. | £7 | £7 | £8 | £17 |
| Total NC Liab. | £114 | £113 | £115 | £130 |
| Other Liabilities | £0 | £0 | £0 | £0 |
| Cap. Leases | £64 | £69 | £71 | £73 |
| Total Liabilities | £184 | £171 | £174 | £175 |
| Equity | – | – | – | – |
| Pref Stock | £0 | £0 | £0 | £0 |
| Common Stock | £53 | £53 | £53 | £48 |
| Retained Earnings | -£415 | -£400 | -£390 | -£351 |
| AOCI | £0 | £9 | £9 | -£4 |
| Other Equity | £395 | £395 | £395 | £380 |
| Total Equity | £33 | £57 | £66 | £74 |
| Supplemental Information | – | – | – | – |
| Minority Interest | £0 | £3 | £5 | £4 |
| Total Liab. & Tot. Equity | £216 | £232 | £245 | £252 |
| Net Debt | £52 | £48 | £29 | £11 |